Clinical Trials in Lithuania

• The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting
  2024-518589-29-00 Phase III Bronchiectasis Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
• A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting
  2024-512753-24-00 Phase III Acute Myeloid Leukemia (AML) Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
• A randomized, placebo-controlled trial to evaluate the safety and efficacy of Debio 4126 in patients with acromegaly previously treated with… Recruiting
  2024-516616-24-00 Phase III Acromegaly Debiopharm International S.A.
• A phase 2/3, multi-center, study of L-Annamycin in combination with cytarabine vs. placebo in combination with cytarabine as second line the… Recruiting
  2024-518359-47-00 Phase II/III Acute Myeloid Leukemia Moleculin Biotech Inc.
• Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized cli… Recruiting
  2024-514732-24-00 Phase IV Juvenile idiopathic arthritis IRCCS Istituto Giannina Gaslini
• A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting
  2024-512733-32-00 Phase III Acute Myeloid Leukemia (AML) Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
• IMPACT-AML: A RANDOMIZED PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA Recruiting
  2024-514517-35-00 Phase III Acute myeloid leukemia Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
• A study to compare effects and safety of CT-P51 and Keytruda in patients with previously untreated metastatic lung cancer Recruiting
  2024-514048-98-00 Phase III Previously Untreated Metastatic Non-Squamous Non-Small Cell … Celltrion Inc.
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting
  2024-514135-17-00 Phase III Immunoglobulin A Nephropathy Alpine Immune Sciences Inc.
• Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Recruiting
  2023-504358-36-00 Phase III multiple sclerosis Sanofi-Aventis Recherche & Developpement
• A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participant… Recruiting
  2023-505678-14-00 Phase II Ulcerative Colitis AbbVie Deutschland GmbH & Co. KG
• Effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans… Recruiting
  2023-508694-80-01 Phase IV Patients undergoing antibiotic therapy (in the context of er… Biocodex
• A Phase 3, Open-Label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Trea… Recruiting
  2022-501980-42-00 Phase III Anemia associated with Chronic Kidney Disease Astellas Pharma Global Development Inc.
• Open-label, long-term safety, efficacy, and pharmacokinetics study of vibegron in pediatric subjects 2 years to < 18 years of age with NDO a… Recruiting
  2024-513995-16-00 Phase II/III Neurogenic Detrusor Overactivity (NDO) Sumitomo Pharma America Inc.
• Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting
  2022-500273-14-00 Phase II/III Atherosclerotic cardiovascular disease in patients with ESKD CSL Behring LLC
• A Phase 3 program evaluating the effect of filgotinib in subjects with active axial spondyloarthritis Recruiting
  2022-501354-10-01 Phase III axial spondyloarthritis Alfasigma S.p.A.
• A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting
  2022-500257-16-00 Phase III Diabetic Foot Infections Micurx Pharmaceuticals Inc.
• Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting
  2022-502503-30-00 Phase III Acute lymphoblastic leukemia Princess Maxima Center For Pediatric Oncology
• A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Recruiting
  2025-523544-12-00 Phase III Myelodysplastic neoplasms/syndromes (MDS) Takeda Development Center Americas Inc.
• SAFEGUARD (SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes) Study Recruiting
  2025-521560-36-00 Phase II Type 1 Diabetes Sab Biotherapeutics Inc.
• A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting
  2025-521546-23-00 Phase III Secondary progressive multiple sclerosis Novartis Pharma AG
• Phase 3 Study of Barzolvolimab in Participants with Cold Induced Urticaria and Symptomatic Dermographism Recruiting
  2025-522583-32-00 Phase III Cold-Induced Urticaria and Symptomatic Dermographism Celldex Therapeutics Inc.
• A clinical study of opevesostat and standard hormone therapy in people with prostate cancer (MK-5684-004) Recruiting
  2023-504957-11-00 Phase III Metastatic castration resistant prostate cancer Merck Sharp & Dohme LLC
• An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting
  2025-521036-11-00 Phase III Immune system disseases Sanofi-Aventis Recherche & Developpement

Showing 25–48 of 245 trials